Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bancroft Charles A
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   168,937    

Indirect Shares

   300,000      
Direct Value   $6,424,696    

Indirect Value

   $12,702,000      
Total Shares   468,937      
Total Value   $19,126,696      


Bristol-Myers Squibb Co $5,823,190 Colgate Palmolive Co $516,916 Kodiak Sciences Inc. $84,590 Bristol-Myers Squibb Co $5,823,190 Colgate Palmolive Co $516,916 Kodiak Sciences Inc. $84,590
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, Head of Integration 2020-03-10 137,534 2020-03-10 300,000    Premium*  
            Colgate Palmolive Co CL Director 2018-05-14 5,455 2017-05-15 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-04-02 25,948 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-06 4 OE $0.00 $0 D/D 7,323 171,251 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-06 4 D $65.12 $414,619 D/D (6,367) 171,702 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-06 4 A $0.00 $0 D/D 6,968 176,853 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-06 4 A $0.00 $0 D/D 6,818 178,069 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4 D $65.53 $531,645 D/D (8,113) 181,609 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 A $0.00 $0 D/D 5,378 184,162 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4 OE $0.00 $0 D/D 13,239 184,290 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-05-20 4 S $70.79 $2,137,838 D/D (30,201) 184,694 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2015-03-10 4 A $0.00 $0 D/D 4,781 185,006 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-11-01 4 D $50.80 $70,917 D/D (1,396) 186,398 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A D $0.00 $0 D/D (92) 186,449 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-11-01 4 OE $0.00 $0 D/D 3,100 187,794 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-12-02 4 D $55.96 $161,333 D/D (2,883) 189,918 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-12-02 4 OE $0.00 $0 D/D 6,403 192,801 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 D $0.00 $0 D/D (92) 193,278 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 OE $0.00 $0 D/D 121,014 199,850 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2018-12-02 4 D $53.46 $145,197 D/D (2,716) 203,401 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2018-12-02 4 OE $0.00 $0 D/D 6,401 206,117 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2017-02-28 4 OE $27.01 $610,372 D/D 22,598 212,516 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A D $64.94 $2,365,569 D/D (36,427) 214,895 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 D $64.94 $2,365,569 D/D (36,427) 221,724 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2017-03-10 4 A $0.00 $0 D/D 3,196 224,650 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2017-03-10 4 D $0.00 $0 D/D (1,659) 229,647 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4/A OE $0.00 $0 D/D 75,618 240,329 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2016-03-10 4 OE $0.00 $0 D/D 75,618 247,158 0 -
  117  Records found
  1   2   3   4  5      
  Page 4 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us